Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$12.46 - $15.48 $12,671 - $15,743
1,017 Added 24.51%
5,166 $65,000
Q1 2023

May 10, 2023

BUY
$14.26 - $22.1 $12,035 - $18,652
844 Added 25.54%
4,149 $64,000
Q2 2020

Aug 05, 2020

BUY
$37.05 - $65.03 $59,613 - $104,633
1,609 Added 94.87%
3,305 $197,000
Q1 2020

May 13, 2020

BUY
$33.63 - $69.4 $4,035 - $8,328
120 Added 7.61%
1,696 $70,000
Q3 2019

Nov 14, 2019

BUY
$19.95 - $38.85 $6,004 - $11,693
301 Added 23.61%
1,576 $53,000
Q2 2019

Aug 14, 2019

BUY
$21.05 - $26.21 $12,103 - $15,070
575 Added 82.14%
1,275 $29,000
Q4 2017

Feb 14, 2018

BUY
$16.54 - $24.2 $11,578 - $16,940
700
700 $16,000

Others Institutions Holding DCPH

About Deciphera Pharmaceuticals, Inc.


  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Ameritas Investment Partners, Inc. Portfolio

Follow Ameritas Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.